Recent studies have shown that anaerobes account for 0.5-9% of all episodes of bacteraemia in hospitalised patients, with variations according to geographical location and demographic characteristics, most notably age, but few data are available for cancer patients. This study investigated retrospectively the incidence of anaerobic bacteraemia in cancer patients who received non-surgical treatment over a 6-year period at a tertiary oncology centre. Gastrointestinal (27%) and haematological (29%) malignancies were the most common underlying diseases. Among 45 isolates of anaerobic bacteria recovered from 45 patients, Bacteroides spp. and Clostridium spp. were the most frequent pathogens (60% and 22%, respectively). Twenty episodes of bacteraemia were polymicrobial, most frequently with aerobic Gramnegative bacilli (18 cases). The mortality rate for patients with adequate antimicrobial therapy from the outset was 14%, compared with 63% for patients who were not treated adequately at any time.
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I N T R O D U C T I O N
Anaerobic bacteraemia is uncommon, accounting for 0.5-9% of all positive blood cultures in hospitals [1] . The effectiveness of antimicrobial therapy in improving outcomes for patients with anaerobic bacteraemia has been challenged, and a vital role for surgery has been suggested [2, 3] , but several studies have shown that anaerobic bacteraemia is often missed on the basis of clinical findings, and that many patients receive inadequate antimicrobial treatment until blood culture results are available [4, 5] . In immunosuppressed patients, although bacteraemia is usually caused by aerobic or facultative bacteria [6] , anaerobic bacteria comprise most of the endogenous microbial flora and can also cause bacteraemia. The mucosal and visceral damage caused by cancer chemotherapy increases the risk of bacteraemia related to endogenous anaerobes.
The objectives of the present study were: to evaluate the incidence and clinical significance of anaerobic bacteraemia, as documented by blood cultures, in cancer patients; to investigate management changes in response to microbiology laboratory reports of anaerobic bacteraemia; and to evaluate the impact of antimicrobial therapy on patient survival.
P A T I E N T S A N D M E T H O D S Setting
The Gustave Roussy Institute is a 400-bed tertiary-care teaching hospital in the Paris area, France, which treats only patients with solid or haematological malignancies. There are 111 medical beds, 155 surgical beds, 35 paediatric beds, 15 intensive care unit beds and 38 other beds.
Patients and definitions
Patients with blood cultures positive for anaerobic bacteria between 1993 and 1998 were identified retrospectively from the microbiology laboratory database. An infectious diseases specialist and a microbiologist reviewed the hospital charts of each patient, abstracting data regarding age, gender, underlying disease, chronic health according to the criteria of McCabe and Jackson [7] , dates of blood culture sampling, dates that blood culture reports were available to clinicians, dates and nature of antimicrobial therapy, body sites positive for anaerobic bacteria, and patient mortality. The definition of focus of infection was based on clinical data, confirmed, whenever possible, by microbiological results.
Pneumonia was defined as the presence of new chest infiltrates, combined with at least one of the major criteria of cough, sputum production or history of fever ( ‡ 38.5°C), or two or more of the minor criteria of dyspnoea, pleuritic chest pain or pulmonary consolidation on clinical examination, and, when available, a microbiological sample. Urinary tract infection was defined as the presence of urinary symptoms suggesting urinary tract infection, combined with a history of fever ( ‡ 38.5°C) and a positive urine culture with a single microorganism ( ‡ 10 5 CFU ⁄ mL). Mucositis was considered when patients with risk-factors (i.e., intensive chemotherapy) had local signs of mucositis corresponding to grade 4 or 5 of the WHO oral toxicity scale. Gastrointestinal infection was considered when clinical features were in agreement with the diagnosis of gastrointestinal infection and no other focus of infection was suspected. Gynaecological infection was defined as clinical features in agreement with a diagnosis of salpingitis. Cellulitis was defined as clinical signs of superficial skin infection. Abscess was defined as a purulent collection, combined with a positive microbiological sample.
Underlying diseases were identified based on the description given by the physician in the medical records. A patient was considered to have heart or liver disease if such a condition was documented as ongoing at the time of the positive blood culture. Shock was defined as presence of any of the following: a sustained (> 1 h) systolic blood pressure decrease of at least 40 mm Hg from baseline; systolic blood pressure < 90 mm Hg after adequate volume replacement; or a need for vasopressors. Hospital-acquired bacteraemia was defined as the occurrence of new symptoms of infection and the onset of bacteraemia ‡ 48 h after hospital admission.
Positive blood cultures were considered to be clinically significant when two or more consecutive cultures were positive for the same organism, or when a single blood culture was positive in a patient who had fever (> 38.5°C) and a documented focus of infection at the time of blood sample collection. Propionibacterium isolates were considered to be contaminants when found in a single blood culture. Antimicrobial treatment was deemed adequate when the microorganism was susceptible in vitro [8] . None of the patients required surgery for the anaerobic infection.
Cultures and susceptibility testing
Each blood sample was inoculated into aerobic and anaerobic blood culture bottles (Vital-duo; bio-Mérieux, Marcy l'Etoile, France) and incubated for 5 days in the automated Vital System (bio-Mérieux). All bottles showing bacterial growth were subcultured on to agar plates and incubated under both aerobic and anaerobic conditions, and bacteria were then identified by conventional methods [9] . Antibiotic susceptibility testing was performed by agar disk-diffusion, with isolates classified as susceptible, intermediate or resistant according to the guidelines of the Comité de l'Antibiogramme de la Société Française de Microbiologie [10] .
Statistical analysis
Results were expressed as medians with 95% CIs. Categorical variables were compared using the chi-square test (or Fisher's exact test where appropriate). Continuous variables were compared using the Wilcoxon rank sum test for unpaired data. Data were analysed by Epi-Info (Centers for Disease Control, Atlanta, GA, USA). All tests were two-sided, and p values < 0.05 were considered significant.
R E S U L T S
During the 6-year study period (1993) (1994) (1995) (1996) (1997) (1998) , 117 834 blood cultures were performed in the hospital; of these, 7989 (6.8%) yielded bacteria. Blood cultures from 46 cancer patients grew anaerobic bacteria (0.6% of all positive blood cultures); however, one patient had a single positive blood culture for Propionibacterium acnes, leaving 45 patients for the study.
Patient characteristics
Of the 45 patients (median age 48 years; range 38-75 years) included in the study, 18 (40%) were female. The underlying diseases are summarised in Table 1 ; 32 (71%) patients had solid tumours and 13 (29%) had haematological malignancies. Chemotherapy had partially failed in 44 patients, and 14 had a recent history of metastatic disease or leukaemia relapse. Administration of chemotherapy within the last 30 days was recorded for 27 (60%) patients, and 19 (42%) were receiving corticosteroid therapy with a daily dosage > 1 mg ⁄ kg. None of the 45 patients received antimicrobial agents within the 2-week period preceding the episode of anaerobic bacteraemia. The median time between the preceding course of chemotherapy and the episode of bacteraemia was 17 days (8-26 days).
All 45 patients were admitted with a fever, usually > 39°C, to a ward or to the intensive care unit for suspected acute infection. On the day of the blood sample yielding the first culture positive for anaerobes, 17 (38%) patients had neutropenia (< 1000 neutrophils ⁄ lL), while the remaining 28 patients had leukocytosis.
Microbiological findings
Approximately two-thirds of the cases of anaerobic bacteraemia were caused either by Bacteroides spp. (27 ⁄ 45; 60%), mainly Bacteroides fragilis (14 ⁄ 45; 31%), or by Gram-positive anaerobes (14 ⁄ 45; 31%), mainly Clostridium perfringens (7 ⁄ 45; 16%) ( Table 2 ). For 20 patients, the blood cultures grew more than one microorganism. Escherichia coli was the microorganism found most commonly in combination with an anaerobe (13 ⁄ 45; 29%) ( Table 3) . Table 4 lists the presumed and confirmed sites of infection with anaerobic bacteria. The focus of infection was presumed in 24 cases, proven in 13 cases and unknown in eight cases. The gastrointestinal tract was the most common presumed source of anaerobic bacteraemia (22 ⁄ 45; 49%), followed by oral mucositis (7 ⁄ 45; 16%), cellulitis and abscesses (3 ⁄ 45), gynaecological infections (2 ⁄ 45), pneumonia (1 ⁄ 45), urinary tract infection (1 ⁄ 45), and pharyngeal abscess (1 ⁄ 45).
Antimicrobial therapy
As infection was the reason for admission, empirical antimicrobial therapy was usually started at admission (43 ⁄ 45; 96%). A single antimicrobial agent was given to eight patients, two antimicrobial agents to 28 patients, and three antimicrobial agents to seven patients. Ceftazidime was the empirical antimicrobial agent used most commonly at admission (29% of patients). Only 13 (29%) patients received adequate antimicrobial treatment, comprising two patients who received amoxycillin-clavulanic acid alone, seven who received amoxycillin-clavulanic acid and ciprofloxacin, and four who received an ureidopenicillin and either an aminoglycoside (two patients) or ciprofloxacin (two patients). However, aminopenicillins, with or without b-lactamase inhibitors, carbapenems and metronidazole were all active against these anaerobic isolates. Among the remaining 32 patients, 16 were switched to adequate antimicrobial agents after blood culture results were obtained, but 16 patients remained on inadequate antimicrobial therapy throughout the course of their infection.
Mortality
The overall hospital mortality was 42% (19 patients), with a median time from the blood culture result to death of 4.5 days (3-16 days). Of these 19 patients, none were deemed terminally ill, and therefore none had care withdrawn. The median time to death after the last positive blood culture was 2 days (4-8 days). The mortality rate was not influenced by age, underlying disease, source of infection, or whether infection was polymicrobial and nosocomial. The mortality rate was 63% (ten patients) in the group that never received adequate antimicrobial treatment, 47% (seven patients) in the group that was switched to adequate antimicrobial therapy when the blood culture result became available, and 14% (two patients) in the group that received adequate antimicrobial therapy from the outset. Immediate adequate antimicrobial therapy was significantly protective against mortality (Table 5 ). Compared to the group that received adequate therapy from the outset, the increased mortality in the group that never received adequate therapy was statistically significant, but the increased mortality in the group switched to adequate therapy was not.
D I S C U S S I O N
Anaerobic bacteraemia is fairly rare in hospitalised patients [3] . However, cancer patients are at high risk for bacterial infection because intensive cancer therapy regimens cause both profound granulocytopenia and disruption of physical barriers [11] . An increase in the incidence of anaerobic bloodstream infections has been reported in patients with cancer [12] and in bone marrow transplant recipients [13] . Mucositis has been identified as a risk-factor for bloodstream infection caused by a variety of microorganisms [14, 15] . Other known risk-factors for anaerobic bloodstream infection include haematological malignancies and a history of prophylactic therapy with quinolones, surgery, or broad-spectrum antimicrobial therapy [12] . In the present study, anaerobes accounted for only 0.6% of all positive blood cultures from hospitalised cancer patients, in accordance with previous reports [3] . The spectrum of causative agents and the sources of infection were also consistent with previous data [16] . Bacteroides spp. were the most common isolates, followed by Gram-positive anaerobes. Lactobacillus and Bifidobacterium, usually considered to be contaminants, caused severe infections in some of these cancer patients. The gastrointestinal tract was the most common source of bacteraemia, both in the present study and in previous studies of nonsurgical patients [2, 16] .
Whereas anaerobes comprise most of the endogenous microflora and can cause bacteraemia when mucosal or visceral damage facilitates their entry into the bloodstream [17] , most data regarding anaerobic bacteraemia come from surgical patients. In contrast, the present study focused on anaerobic bacteraemia in non-surgical cancer patients, with or without neutropenia. Importantly, most of these patients had haematological disease or abdominal cancer. The intensive chemotherapy regimens required to treat haematological malignancies, and the damage to the gut mucosa associated with abdominal cancers, may increase the risk of translocation of anaerobes to the bloodstream [17] . In neutropenic patients, the number of reported anaerobic bloodstream infections has increased in recent years [18, 19] . Among the neutropenic patients in the present study, many had chemotherapy-induced oral mucositis [20] or periodontal disease. Together with the types of anaerobe recovered from these neutropenic patients, this suggests an oral source of infection in a number of cases. Disruption of the mucosal barrier, and antibiotic-related selection pressure on the oral flora in patients with neutropenia, probably facilitate the occurrence of anaerobic bacteraemia. The overall mortality in the present study was high (42%), but consistent with previous studies [21] . In keeping with other studies [16] , many of these patients did not receive antimicrobial agents active against the anaerobes recovered from their blood cultures. Only one-third of patients received adequate antimicrobial treatment before the blood culture results were available, and 38% of patients never received adequate antimicrobial agents. Early adequate antimicrobial therapy is the cornerstone of treatment for acquired infections. Empirical antimicrobial therapy consists of selecting agents effective against the pathogens most likely to be responsible for the clinically suspected infection. Early administration of antimicrobial agents active against the microorganisms responsible for severe infections in hospitalised patients is essential; inadequate antimicrobial therapy affected outcomes adversely in patients with pneumonia, peritonitis, bacteraemia or meningitis [22, 23] . Inadequate antimicrobial treatment in critically-ill patients with bloodstream infections has been associated with a higher rate of hospital mortality, compared with the rate in patients who received adequate treatment [24] . In the present study, adequate antibiotic therapy was the only factor associated with better survival; thus, survival was not dependent on underlying disease, source of infection, or the recovery of more than one organism [25] . However, these factors were uncommon among the participants in the present study, and consequently the statistical power for identifying them as risk-factors was limited.
Most cases of bacteraemia in cancer patients are caused by facultative Gram-negative bacilli and Gram-positive cocci. Few studies have focused on the role of bacteraemia caused by strict anaerobes in cancer patients [16, 21] , although several risk-factors for anaerobic infections exist in this population. Given the high mortality associated with anaerobic bacteraemia in cancer patients, the present study confirms the opinion of Patel et al. [14] that anaerobic infection should be considered when selecting initial antimicrobial agents for febrile cancer patients, with or without neutropenia, most notably those with oral mucositis or a history of invasive procedures on the gastrointestinal tract. Anaerobic blood cultures should be performed routinely in these patients, as the results may help to correct the choice of antimicrobial agents when the initial regimen does not include drugs active against anaerobes. However, clinicians must bear in mind the side-effects of antibiotics that are active against anaerobes. In several studies, exposure to these antibiotics was correlated significantly with colonisation and infection by vancomycin-resistant enterococci. Moreover, studies have shown that antibiotics active against anaerobes promote intestinal overgrowth of nosocomial pathogens [26] [27] [28] .
In conclusion, the present study showed that anaerobic bacteraemia in cancer patients was associated with intra-abdominal tumours and haematological malignancies. Pathogen distribution was the same as for non-cancer patients. Empirical antimicrobial regimens were not consistently effective against anaerobes. Effective antimicrobial therapy from the outset was associated with a higher survival rate. Patients with abdominal cancer or haematological malignancies and evidence of acute infection should be given empirical antimicrobial agents active against anaerobes. Furthermore, anaerobe growth in a blood culture should be considered clinically important, as failure to give adequate treatment for aerobic bacteraemia may seriously decrease a patient's chance of survival.
